Value through Innovation27 July 2016

What is a lay summary?

Clinical Study Results

  • CATAPRESAN ® - Healthy
    Clinical Study Number 253.2486
    Study Indication Healthy
    Product CATAPRESAN ®
    Generic Name Clonidine
    Lab Code
    Clinical Phase I
    Study Title

    A randomised, double-blind study designed to assess the bioequivalence and adhesion properties of transdermal clonidine-VistanexTM compared to transdermal clonidine-Oppanol® following transdermal administration in healthy male and female volunteers

    Study Document
    Trial synopsis 253.2486 english